DR. CHRISTOPHER P DAVOLOS OD
Prescription History 1013961663
Optometrist in Wilmington, DE
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHRISTOPHER P DAVOLOS OD, an active Optometrist specialist practicing in Wilmington, DE. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 370 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 101 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other DE PrescribersVs. DE Avg |
|---|---|---|---|
| Latanoprost | 101 | $20.79▼ below DE avg | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 101 Medicare prescriptions for Latanoprost, about 78% of the volume of the typical Delaware prescriber of this medication (130). Medicare paid an average of $20.79 per fill, versus $22.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 198.7 30-Day Fills standardized to 30-day supplies 5,788 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 65 | $21.88▼ below DE avg | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 65 Medicare prescriptions for Dorzolamide-Timolol, about the same volume as the typical Delaware prescriber of this medication (71). Medicare paid an average of $21.88 per fill, versus $29.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 150.3 30-Day Fills standardized to 30-day supplies 4,466 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 40 | $316.52▼ below DE avg | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 40 Medicare prescriptions for Combigan, about 1.4 times the volume of the typical Delaware prescriber of this medication (28). Medicare paid an average of $316.52 per fill, versus $485.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,369 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 36 | $10.86▼ below DE avg | ≈ Typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 36 Medicare prescriptions for Erythromycin, about 80% of the volume of the typical Delaware prescriber of this medication (45). Medicare paid an average of $10.86 per fill, versus $12.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 36 30-Day Fills standardized to 30-day supplies 438 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 31 | $38.10 | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 31 Medicare prescriptions for Timolol Maleate, about half the volume of the typical Delaware prescriber of this medication (64). Medicare paid an average of $38.10 per fill, versus $26.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51.8 30-Day Fills standardized to 30-day supplies 1,519 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 26 | $11.48▼ below DE avg | ≈ Typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 26 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 79% of the volume of the typical Delaware prescriber of this medication (33). Medicare paid an average of $11.48 per fill, versus $13.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 26 30-Day Fills standardized to 30-day supplies 316 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 25 | $1,880.71 | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 25 Medicare prescriptions for Xiidra, about the same volume as the typical Delaware prescriber of this medication (24). Medicare paid an average of $1,880.71 per fill, versus $1,076.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69 30-Day Fills standardized to 30-day supplies 2,070 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 18 | $503.26▼ below DE avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 18 Medicare prescriptions for Lumigan, about half the volume of the typical Delaware prescriber of this medication (41). Medicare paid an average of $503.26 per fill, versus $544.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 36.6 30-Day Fills standardized to 30-day supplies 1,097 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 15 | $35.97▼ below DE avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 15 Medicare prescriptions for Prednisolone Acetate, about 16% of the volume of the typical Delaware prescriber of this medication (92). Medicare paid an average of $35.97 per fill, versus $50.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 18.5 30-Day Fills standardized to 30-day supplies 391 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 13 | $142.92 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 13 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical Delaware prescriber of this medication (56). Medicare paid an average of $142.92 per fill, versus $70.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.9 30-Day Fills standardized to 30-day supplies 983 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. CHRISTOPHER P DAVOLOS OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Wilmington, DE practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among DE prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
